4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.07
+0.46 (4.79%)
Jul 30, 2026, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $526.42 million as of July 30, 2026. Its market cap has increased by 160.64% in one year.
Market Cap
526.42M
Enterprise Value
89.33M
1-Year Change
160.64%
Ranking
Category
Stock Price
$10.07
ChartMarket Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $526.42M, a decrease of -9.30%. That is a compound annual growth rate of -1.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 526.42M | 22.85% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 540.83M |
| Arvinas | 532.30M |
| Contineum Therapeutics | 527.15M |
| Shattuck Labs | 519.89M |
| Zura Bio | 518.69M |
| Ginkgo Bioworks Holdings | 517.70M |
| Eikon Therapeutics | 512.15M |
| Artiva Biotherapeutics | 509.20M |